Group | |||
Notes | Year to | Year to | |
31-Dec-23 | 31-Dec-22 | ||
£'000 | £'000 | ||
Revenue | |||
Administrative expenses | 6 | ( | ( |
Provision for impairment charges | 7 | ( | |
Share-based payment expense | 22 | ( | ( |
Other income | 4 | ||
Gains on disposal of property plant and equipment | |||
Operating loss | ( | ( | |
Interest payable and similar charges | 8 | ( | ( |
Loss before tax | ( | ( | |
Tax expense | 9 | ||
Loss after tax | ( | ( | |
Other comprehensive income: | |||
Items that may be reclassified to profit or loss | |||
Loss on translation of foreign operations | ( | ( | |
Total comprehensive loss | ( | ( | |
Loss per share | |||
Basic and diluted loss per share (pence) | 10 | ( | ( |
Group | Company | ||||
Notes | 31-Dec-23 | 31-Dec-22 | 31-Dec-23 | 31-Dec-22 | |
£'000 | £'000 | £'000 | £'000 | ||
Non-current assets | |||||
Investments | 11 | 3,206 | 3,241 | ||
Intangible exploration and evaluation assets | 13 | - | - | ||
Trade and other receivables | 15 | - | 6 | ||
Property, plant and equipment | 14 | 7 | 6 | ||
Total non-current assets | 3,213 | 3,253 | |||
Current assets | |||||
Trade and other receivables | 15 | 218 | 266 | ||
Cash and cash equivalents | 16 | 17 | 41 | ||
Total current assets | 235 | 307 | |||
Total assets | 3,448 | 3,560 | |||
Equity and liabilities | |||||
Share capital | 21 | 10,892 | 9,647 | ||
Share premium | 21 | 2,177 | 2,177 | ||
Share-based compensation reserve | 22 | 2,442 | 2,441 | ||
Interest in shares in EBT | 22 | ( | ( | (839) | (839) |
Translation reserve | ( | ( | - | - | |
Accumulated losses | ( | ( | (13,144) | (11,783) | |
Merger relief reserve | 1,200 | 1,200 | |||
Total equity | 2,728 | 2,843 | |||
Current liabilities | |||||
Trade and other payables | 17 | 329 | 366 | ||
Deferred consideration | 18 | 166 | 200 | ||
Borrowings | 19 | 225 | - | ||
Total current liabilities | 720 | 566 | |||
Non-current liabilities | |||||
Borrowings | 19 | - | 151 | ||
Total non-current liabilities | - | 151 | |||
Total equity and liabilities | 3,448 | 3,560 |
Share-based | Interest | Merger | |||||||
Share | Share | compensation | in | Translation | Other | relief | Accumulated | Total | |
capital | premium | shares | reserve | reserve | losses | ||||
reserve | in EBT | reserve | |||||||
£'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
At 1 January | |||||||||
2022 | ( | ( | ( | ||||||
Loss for the year | ( | ( | |||||||
Other comprehensive | |||||||||
loss | ( | ( | |||||||
Transactions | |||||||||
with owners: | |||||||||
Discounting of loan notes | ( | ( | |||||||
Transfer from other reserve to accumulated | |||||||||
losses | ( | ||||||||
Share based | |||||||||
compensation | ( | ||||||||
Issue of new | |||||||||
shares | |||||||||
At 31 December | |||||||||
2022 | ( | ( | ( | ||||||
Loss for the year | ( | ( | |||||||
Other comprehensive | |||||||||
loss | ( | ( | |||||||
Transactions | |||||||||
with owners: | |||||||||
Share based | |||||||||
compensation | |||||||||
Issue of new | |||||||||
shares | |||||||||
At 31 December | |||||||||
2023 | ( | ( | ( |
Note | Group | Company | |||
31-Dec-23 | 31-Dec-22 | 31-Dec-23 | 31-Dec-22 | ||
£’000 | £’000 | £’000 | £’000 | ||
Cash flow from operating activities | |||||
Loss after tax | ( | ( | (1,361) | (5,433) | |
Adjustments for: | |||||
Depreciation | - | - | |||
Share-based payment expense | 22 | 1 | 335 | ||
Expenses settled by issue of shares | 21 | 339 | 50 | ||
Interest expense | 8 | 54 | 7 | ||
Gains on disposal of property plant and equipment | ( | - | - | ||
Farm out gain | ( | ||||
Discounting on deferred consideration | ( | ||||
Inter-company interest expense / (income) | - | (264) | |||
Provisions for expected credit losses | - | 2,444 | |||
Provision for impairment of investments | 11 | - | 2,261 | ||
Provision for impairment of goodwill | - | - | |||
Provision for impairment of property plant and equipment | 14 | - | - | ||
Foreign exchange gains | ( | - | - | ||
Operating loss before working capital | |||||
changes | ( | ( | (968) | (600) | |
Changes in working capital: | |||||
(Increase) / decrease in trade & other receivables | ( | 53 | 89 | ||
(Decrease) / increase in trade & other payables | (35) | 117 | |||
Net cash outflows from operating activities | ( | ( | (950) | (394) | |
Cash flow from investing activities | |||||
Purchase of plant and equipment | ( | ( | - | (6) | |
Proceeds from disposal of plant and equipment | - | - | |||
Capitalised E&E expenditure | ( | - | - | ||
Asset acquisition including directly attributable | |||||
costs | ( | - | (108) | ||
Funds advanced to subsidiaries | - | (482) | |||
Net cash used in investing activities | ( | ( | - | (596) | |
Cash flow from financing activities | |||||
Loan received | 23 | 342 | 150 | ||
Net proceeds from director loans | 127 | - | |||
Interest paid | ( | (22) | - | ||
Cash proceeds from issue of shares | 479 | 691 | |||
Net cash flow from financing activities | 926 | 841 | |||
Net increase/(decrease) in cash & cash | |||||
equivalents | ( | ( | (24) | (149) | |
Cash & cash equivalents at beginning of the year | 41 | 190 | |||
Cash and cash equivalents at end of the year | 17 | 41 |